Prospective Memory in Parkinson's Disease

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00913640

Acronym

ProMem

Enrollment

Registered

2009-06-04

Start date

2009-11-18

Completion date

2010-08-27

Last updated

2022-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Memory, Parkinson's Disease, Prospective Memory

Keywords

Prospective Memory Performance, Prospective Memory Outcome, Parkinson's Disease

Brief summary

The investigators tested whether prospective memory is impaired in individuals with Parkinson's Disease compared to controls using reliable and validated experimental measures. Also, the investigators assessed the impact of Parkinson's medication on prospective memory performance in PD to better estimate prospective memory function in PD patients' everyday (chronically treated) life.

Interventions

None listed

Study design

Observational model

CASE_CONTROL

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

ALL

Age

40 Years to 70 Years

Healthy volunteers

Yes

Inclusion criteria

* PD Group: * Clinically definite PD * 40-70 years old * Hoehn and Yahr stage I,II,III * Currently treated with Levodopa/carbidopa * Control Group: * 40-70 years old * Spouses of PD Group preferred

Exclusion criteria

* PD Group and Control Group: * Significant neurological problems * Significant current psychiatric diagnoses * Mini Mental Status Exam score \< 24 (MMSE) * Any significant abnormality on brain imaging * MPTP exposure * Control Participants met the same

Design outcomes

Primary

Measure	Time frame	Description
Virtual Week	One session at baseline.	Prospective Memory Task; Score range is 0-100%, with higher scores being better performance.

Countries

United States

Outcome results